minor cannabinoids list and benefits
A shopper's guide to the minor cannabinoids list and benefits — CBG, CBC, CBN, THCV, CBDV and more — plus how to read labels before buying.
CBG, CBN and THCV are cannabinoids found in cannabis at low levels. CBG is a precursor to THC and CBD. CBN forms when THC oxidizes. THCV has a shorter side chain than THC. Each has research behind it, but human trial data is thin. None of the three has FDA approval as a drug.
CBGA is the acid form. Enzymes convert CBGA into CBDA and THCA. CBG content in dried flower runs under 1% to 2% in most samples. CBG binds CB1 and CB2 receptors with low strength. A 2021 review in PubMed Central lists glaucoma, inflammatory bowel disease and bacterial growth as research targets. Human trials are small and few.
minor cannabinoids list and benefits
CBN comes from THC. Light, heat and time convert THC to CBN. Aged cannabis holds more CBN than fresh cannabis. CBN binds CB1 with less strength than THC. Marketing calls it a sleep aid. Reviews found no large human trial that tested CBN alone for sleep. Most sleep data comes from THC and CBN mixes.
THCV has a 3-carbon side chain. THC has a 5-carbon chain. In lab and animal studies, low doses block CB1 and high doses activate CB1. Human data comes from small trials. Plant content sits below 1% in most strains.
State-licensed labs test cannabinoid content. HPLC is the common method. A label should list CBG, CBN and THCV in mg per package. The FDA does not review these claims. Ask for a batch certificate of analysis. Check the harvest date. CBN rises as THC breaks down, so an old batch can test higher for CBN.
Minor cannabinoid content varies by strain, harvest time and storage. A product label with no batch number gives no way to check the test. Dose ranges in human studies do not match the doses in retail products. Research on CBG, CBN and THCV is early. Treat marketing claims as claims, not results.